Science Explorer Back to mapMap
Discussion
Company · Bergen · Norway

Pharmaq (Norway)

smoltportalen.hi.noROR OpenAlex
Research works
58
▲ 16% vs 2018-21
Citations
1.7k
29.1 per fractional work
Top-10% rate
12.0%
all institutions 10.0%
Open access
44%
world 40%
International
33%
world 18%
Pharmaq (Norway)

Not ranked overall: Pharmaq (Norway) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pharmaq (Norway) work in?

In all years, 65% of research at Pharmaq (Norway) is in Life Sciences, 21% in Physical Sciences. Its largest fields are Immunology and Microbiology (30%), Biochemistry, Genetics and Molecular Biology (20%), Environmental Science (15%). It does 3.5× the world's share of Life Sciences.

Life Sciences: 38 fractional works · 65.3% of its workImmunology and Microbiology: 17 fractional works · 30.0% of its workImmunology: 14 fractional works · 24.4% of its workMicrobiology: 3 fractional works · 4.5% of its workParasitology: 0 fractional works · 0.7% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.4% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 20.0% of its workMolecular Biology: 4 fractional works · 6.6% of its workEndocrinology: 3 fractional works · 5.7% of its workCancer Research: 2 fractional works · 3.9% of its workGenetics: 1 fractional works · 1.8% of its workMolecular Medicine: 0 fractional works · 0.8% of its workCell Biology: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 9 fractional works · 15.1% of its workAnimal Science and Zoology: 4 fractional works · 6.3% of its workAquatic Science: 3 fractional works · 5.7% of its workGeneral Agricultural and Biological Sciences: 1 fractional works · 1.7% of its workFood Science: 0 fractional works · 0.7% of its workPlant Science: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 12 fractional works · 20.7% of its workEnvironmental Science: 9 fractional works · 15.4% of its workEcology: 5 fractional works · 8.0% of its workNature and Landscape Conservation: 2 fractional works · 3.2% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 2.4% of its workGlobal and Planetary Change: 1 fractional works · 0.9% of its workPollution: 0 fractional works · 0.9% of its workMaterials Science: 1 fractional works · 1.9% of its workPolymers and Plastics: 1 fractional works · 1.2% of its workBiomaterials: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 1.9% of its workOrganic Chemistry: 1 fractional works · 1.3% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workEarth and Planetary Sciences: 0 fractional works · 0.7% of its workPaleontology: 0 fractional works · 0.7% of its workEngineering: 0 fractional works · 0.4% of its workOcean Engineering: 0 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workHealth Sciences: 8 fractional works · 13.0% of its workMedicine: 7 fractional works · 11.8% of its workInfectious Diseases: 1 fractional works · 2.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.6% of its workPharmacology: 1 fractional works · 1.6% of its workEpidemiology: 1 fractional works · 1.2% of its workHematology: 1 fractional works · 1.2% of its workSurgery: 1 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.2% of its workNursing: 1 fractional works · 0.9% of its workNutrition and Dietetics: 1 fractional works · 0.9% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 1.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.9% of its workEconomics and Econometrics: 0 fractional works · 0.9% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKPharmaq (Norway)58fractional works, all years
Life Sciences65%Physical Sciences21%Health Sciences13%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Immunology and Microbiology1730.0%
    2. Biochemistry, Genetics and Molecular Biology1220.0%
    3. Agricultural and Biological Sciences915.1%
    4. Neuroscience00.2%
    1. Environmental Science915.4%
    2. Materials Science11.9%
    3. Chemistry11.9%
    4. Earth and Planetary Sciences00.7%
    5. Engineering00.4%
    6. Computer Science00.3%
    1. Medicine711.8%
    2. Nursing10.9%
    3. Veterinary00.3%
    1. Economics, Econometrics and Finance00.9%
    2. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.03× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.26× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 24.66× its world share, 4 worksImmunology and Micro…Neuroscience: 0.50× its world share, 0 worksNeuroscienceChemistry: 0.47× its world share, 0 worksChemistryEarth and Planetary Sciences: 1.62× its world share, 0 worksEarth and Planetary …Engineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 3.62× its world share, 3 worksEnvironmental ScienceMedicine: 0.78× its world share, 2 worksMedicineNursing: 0.24× its world share, 0 worksNursingBusiness, Management and Accounting: 0.13× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 24.7×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology24.66×4 works
  2. Biochemistry, Genetics and Molecular Biology4.26×4 works
  3. Environmental Science3.62×3 works
  4. Agricultural and Biological Sciences3.03×2 works
  5. Earth and Planetary Sciences1.62×0 works
  6. Medicine0.78×2 works
  7. Neuroscience0.50×0 works
  8. Chemistry0.47×0 works
  9. Nursing0.24×0 works
  10. Business, Management and Accounting0.13×0 works
  11. Engineering0.03×0 works

Who are the top researchers at Pharmaq (Norway)?

Ranked on the quality score, Kjersti Gravningen lead among researchers whose main affiliation is Pharmaq (Norway).

  1. 1 Kjersti Gravningen Norway · #2,012,048 worldwide 1.2k citations · 24 works
All ranked researchers at Pharmaq (Norway)

What are the most cited papers from Pharmaq (Norway)?

The most cited paper from Pharmaq (Norway) is "Status and future perspectives of vaccines for industrialised fin-fish farming" (Bjørn Erik Brudeseth, Rune Wiulsrød, Børge Nilsen Fredriksen et al., 2013), with 303 citations. Next come "Cardiomyopathy Syndrome of Atlantic Salmon (Salmo salar L.) Is Caused by a Double-Stranded RNA Virus of the Totiviridae Family" (193) and "Disturbance of the intestinal mucosal immune system of farmed Atlantic salmon (Salmo salar), in response to long-term hypoxic conditions" (156).

Most cited papers
#PaperReleasedCitations
1 Status and future perspectives of vaccines for industrialised fin-fish farming Bjørn Erik Brudeseth, Rune Wiulsrød, Børge Nilsen Fredriksen et al. · Fish & Shellfish Immunology 12 Jun 2013 303
2 Cardiomyopathy Syndrome of Atlantic Salmon (Salmo salar L.) Is Caused by a Double-Stranded RNA Virus of the Totiviridae Family Øyvind Haugland, Aase B. Mikalsen, Pål Nilsen et al. · Journal of Virology Open access 16 Mar 2011 193
3 Disturbance of the intestinal mucosal immune system of farmed Atlantic salmon (Salmo salar), in response to long-term hypoxic conditions L.‐G. NIKLASSON, Henrik Sundh, F. Fridell et al. · Fish & Shellfish Immunology 22 Sep 2011 156
4 A novel systemic granulomatous inflammatory disease in farmed Atlantic cod, Gadus morhua L., associated with a bacterium belonging to the genus Francisella Anne Berit Olsen, Jarle Mikalsen, Marit Rode et al. · Journal of Fish Diseases May 2006 121
5 Intestinal barrier function of Atlantic salmon (Salmo salar L.) post smolts is reduced by common sea cage environments and suggested as a possible physiological welfare indicator Henrik Sundh, Bjørn Olav Kvamme, F. Fridell et al. · BMC Physiology Open access 2010 107
All 60 most cited papers, with filters and sorting

Which keywords describe research at Pharmaq (Norway)?

By fractional works in all years, weighted toward what it does more of than the world: Aquaculture, Antibiotic Resistance, Innate Immunity, Cytokines, Viral Diseases, Fish Immunology, Probiotics and Epidemiology.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Aquaculture15▲ 102×4 topics
  2. Antibiotic Resistance13▲ 57×6 topics
  3. Innate Immunity12▲ 62×3 topics
  4. Cytokines12▲ 78×2 topics
  5. Viral Diseases12▲ 241×2 topics
  6. Fish Immunology12▲ 461×1 topic
  7. Probiotics12▲ 84×1 topic
  8. Epidemiology10▲ 4.2×17 topics
  9. Genomic Sequencing6▲ 69×2 topics
  10. Pathogenesis5▲ 16×8 topics
  11. Biodiversity5▲ 12×4 topics
  12. Metagenomics5▲ 63×2 topics
  13. Immune Response4▲ 12×4 topics
  14. Vaccine4▲ 19×4 topics
  15. Molecular Phylogeny4▲ 36×3 topics
  16. Coronavirus4▲ 53×2 topics
  17. Invasive Species4▲ 11×3 topics
  18. Antimicrobial Resistance4▲ 24×4 topics
  19. Climate Change4▲ 2.3×8 topics
  20. Circovirus3▲ 159×1 topic
  21. Porcine Reproductive and Respiratory Syndrome Virus3▲ 159×1 topic
  22. Cholera3▲ 208×1 topic
  23. Vibrio cholerae3▲ 208×1 topic
  24. Omega-3 Fatty Acids3▲ 55×2 topics
  25. Host-Pathogen Interactions3▲ 45×3 topics
  26. Vaccine Development3▲ 15×2 topics
  27. Mycoplasma3▲ 147×1 topic
  28. Pasteurella3▲ 147×1 topic
  29. Virulence Factors3▲ 24×2 topics
  30. Fish Feed2▲ 72×1 topic
  31. Nutrition2▲ 9.7×1 topic
  32. Aquatic Environment2▲ 51×2 topics
  33. Phylogeny2▲ 22×2 topics
  34. Myxozoan2▲ 1077×1 topic
  35. Parasite2▲ 122×1 topic
  36. Genomics2▲ 10×3 topics
  37. Biomarkers2▲ 5.7×3 topics
  38. Ecosystem2▲ 22×1 topic
  39. Parasites2▲ 79×1 topic
  40. Fisheries Sustainability2▲ 23×2 topics

Which research topics does Pharmaq (Norway) publish most on?

By volume in 2022-now: Aquaculture disease management and microbiota, Aquaculture Nutrition and Growth, Myxozoan Parasites in Aquatic Species and Fish Ecology and Management Studies.

Aquaculture disease mana…3Aquaculture disease management and microbiota: 3 fractional worksAquaculture Nutrition an…1Aquaculture Nutrition and Growth: 1 fractional worksMyxozoan Parasites in Aq…1Myxozoan Parasites in Aquatic Species: 1 fractional worksFish Ecology and Management Studies: 1 fractional worksAnimal Virus Infections Studies: 1 fractional worksVibrio bacteria research…1Vibrio bacteria research studies: 1 fractional worksPhysiological and biochemical adaptations: 1 fractional worksEnvironmental Toxicology and Ecotoxicology: 1 fractional worksParasite Biology and Host Interactions: 0 fractional worksFish Biology and Ecology Studies: 0 fractional works
ImmunologyAquatic ScienceCancer ResearchNature and Landscape Conservation4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Aquaculture disease management and microbiota Immunology 3 works
  2. 2 Aquaculture Nutrition and Growth Aquatic Science 1 works
  3. 3 Myxozoan Parasites in Aquatic Species Cancer Research 1 works
  4. 4 Fish Ecology and Management Studies Nature and Landscape Conservation 1 works
  5. 5 Animal Virus Infections Studies Animal Science and Zoology 1 works
  6. 6 Vibrio bacteria research studies Endocrinology 1 works
  7. 7 Physiological and biochemical adaptations Ecology 1 works
  8. 8 Environmental Toxicology and Ecotoxicology Health, Toxicology and Mutagenesis 1 works
  9. 9 Parasite Biology and Host Interactions Ecology 0 works
  10. 10 Fish Biology and Ecology Studies Aquatic Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.6%not open56.4%

World: 40% of research is openly available.

with international co-authors32.8%domestic only67.2%

World: 18% is written across borders.

How has Pharmaq (Norway)'s research output changed?

Output in 2022-2025 was 16% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pharmaq (Norway) as a percentage of every work published that year, 0.000065% in 2024.

still counting0.00010%0.00020%Pharmaq (Norway)0.000037% in 20251990200020102020

Fractional works of Pharmaq (Norway) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bergen

All research institutions in Bergen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pharmaq (Norway). Posts are plain text and can be reported.